Log In
Print
BCIQ
Print
Print this Print this
 

Conjumab-A (IN-N01-OX2, N01-OX2)

  Manage Alerts
Collapse Summary General Information
Company Intellect Neurosciences Inc.
DescriptionHumanized IgG4 mAb targeting beta amyloid conjugated to OX2, a small molecule anti-oxidant and protein aggregation inhibitor
Molecular Target
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today